Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. VSports app下载.

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

Review
. 2016 Jun 29;5(7):63.
doi: 10.3390/jcm5070063.

Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transition

Affiliations
Review

"V体育官网" Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transition

Aristidis Moustakas et al. J Clin Med. .

Abstract

Transitory phenotypic changes such as the epithelial-mesenchymal transition (EMT) help embryonic cells to generate migratory descendants that populate new sites and establish the distinct tissues in the developing embryo. The mesenchymal descendants of diverse epithelia also participate in the wound healing response of adult tissues, and facilitate the progression of cancer. EMT can be induced by several extracellular cues in the microenvironment of a given epithelial tissue. One such cue, transforming growth factor β (TGFβ), prominently induces EMT via a group of specific transcription factors. The potency of TGFβ is partly based on its ability to perform two parallel molecular functions, i. e. to induce the expression of growth factors, cytokines and chemokines, which sequentially and in a complementary manner help to establish and maintain the EMT, and to mediate signaling crosstalk with other developmental signaling pathways, thus promoting changes in cell differentiation. The molecules that are activated by TGFβ signaling or act as cooperating partners of this pathway are impossible to exhaust within a single coherent and contemporary report. Here, we present selected examples to illustrate the key principles of the circuits that control EMT under the influence of TGFβ. VSports手机版.

Keywords: epithelial-mesenchymal transition; signal transduction; transcription factor; transforming growth factor β; tumor invasiveness V体育安卓版. .

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of EMT (epithelial–mesenchymal transition) and MET (mesenchymal–epithelial transition) in the context of carcinoma progression. Hyperplastic epithelial cells (light green cytoplasm) are shown aligned along their basement membrane (thick black line). Carcinoma cells develop in this primary tumor (deep green cytoplasm) and some undergo EMT, forming mesenchymal cells (black cytoplasm) that degrade the basement membrane and invade the local microenvironment. EMT and invasiveness are enhanced by auxiliary paracrine signals from stromal fibroblasts and immune cells, thus facilitating the movement of mesenchymal cells to the blood or lymphatic vessels where they can intravasate. Upon successful survival in the lymphatic or vascular circulation, some mesenchymal cells extravasate and initiate micrometastases consisting of mesenchymal cells and a bulk of carcinoma cells (deep green cytoplasm) that are generated via MET. The cell types of the schematic are explained below the picture.
Figure 2
Figure 2
Summary of TGFβ signaling during EMT. Inactive TGFβ ligand (bound to its N-terminal latency associated peptide) is present in the extracellular space. After activation, TGFβ binds to the cell surface receptors. In the ligand-bound receptor complex, the type II receptor (TGFβRII) phosphorylates the juxtamembrane domain (small box with the symbol P) of the type I receptor (TGFβRI), which causes activation of Smad or other signaling proteins (collectively referred to as non-Smad pathways). These pathways positively or negatively regulate gene transcription; examples of target genes are given in the figure. The products of these genes often cooperate with the Smad and non-Smad signaling pathways to regulate expression of a second tier of genes, leading to the downregulation of epithelial genes and the upregulation of mesenchymal genes. These genes are classified in four functional groups based on their primary cellular functions (bottom grey boxes). On the left side of the pathway, the regulatory mechanisms are highlighted.
Figure 3
Figure 3
Crosstalk between TGFβ and other signaling pathways during EMT. TGFβ signaling is listed together with six additional signaling pathways. Each pathway is summarized above the dotted line. Secreted growth factors that initiate the pathways are listed in bold on the top. Signaling mediators are listed below the dotted line in the grey boxes. All pathways interact with each other in regulating the expression and/or activity of transcription factors that elicit the EMT. Examples of such transcriptional regulators are shown. The Ras small GTPase is highlighted due to its central role in the process of tumorigenesis and EMT. The downstream kinase pathways initiated by Ras are shown separately. TGFβ is known to induce expression of ligands for many other pathways (top arrows). Upon activation of transcription, many pathways induce the expression of TGFβ family ligands (bottom straight and dotted arrows).

"VSports注册入口" References

    1. Nieto M.A. Epithelial plasticity: A common theme in embryonic and cancer cells. Science. 2013;342:1234850. doi: 10.1126/science.1234850. - DOI - PubMed
    1. Gonzalez D.M., Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci. Signal. 2014:7. doi: 10.1126/scisignal.2005189. - DOI - PMC - PubMed
    1. Van Meeteren L.A., ten Dijke P. Regulation of endothelial cell plasticity by TGF-β. Cell. Tissue Res. 2012;347:177–186. doi: 10.1007/s00441-011-1222-6. - DOI - PMC - PubMed
    1. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 2009;119:1420–1428. doi: 10.1172/JCI39104. - VSports手机版 - DOI - PMC - PubMed
    1. Moustakas A., Heldin C.-H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007;98:1512–1520. doi: 10.1111/j.1349-7006.2007.00550.x. - DOI - PMC - PubMed